                               SEQUENCE LISTING

<110> ABREOS BIOSCIENCES, INC.
 
<120> DETECTION AND QUANTIFICATION OF NATALIZUMAB

<130> 47085-712.601

<140>
<141>

<150> 62/374,217
<151> 2016-08-12

<160> 30    

<170> PatentIn version 3.5

<210> 1
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Ala Cys Pro Met Asn Glu Ser Lys Phe Cys Gly Gly Gly 
1               5                   10              


<210> 2
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Ala Cys Pro Ser Asn Pro Ser Lys Phe Cys Gly Gly Gly 
1               5                   10              


<210> 3
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Ala Cys Asn Trp Met Ile Asn Lys Glu Cys Gly Gly Gly 
1               5                   10              


<210> 4
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Ala Cys Pro Lys Asn Pro Asn Lys Phe Cys Gly Gly Gly 
1               5                   10              


<210> 5
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Ala Cys Val Pro Ser Lys Pro Gly Leu Cys Gly Gly Gly 
1               5                   10              


<210> 6
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Asn Phe Leu Gly Ala Val Ala Lys Gly Ala Ile His Gly Gly Gly 
1               5                   10                  15  


<210> 7
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
His Ala Ser Trp Leu Gly Ser Ser Ser Asn Val Arg Gly Gly Gly 
1               5                   10                  15  


<210> 8
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Thr Ala Met Ala Ser Thr Ser Thr Met Leu Gln His Gly Gly Gly 
1               5                   10                  15  


<210> 9
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
His Phe Ile Asn Val Ser Gly Leu Ala Thr Val Phe Gly Gly Gly 
1               5                   10                  15  


<210> 10
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Arg Asp Tyr His Pro Arg Asp His Thr Ala Thr Trp Gly Gly Gly 
1               5                   10                  15  


<210> 11
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Gln Met Ala Met Glu Gln Thr Asn Ala Asp Tyr Gln Gly Gly Gly 
1               5                   10                  15  


<210> 12
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Leu Pro Thr Asn Glu Ser Ser Pro Lys Gly Ser Asn Gly Gly Gly 
1               5                   10                  15  


<210> 13
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Gln Thr Leu Asn His Ser Trp Leu His Thr Phe Ile Gly Gly Gly 
1               5                   10                  15  


<210> 14
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Val Ser Arg Pro Ala Glu Thr Thr Pro Arg Leu Thr Gly Gly Gly 
1               5                   10                  15  


<210> 15
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Ser Pro Phe His Ser Pro Arg Cys Gly Thr Ala Asn Ser Tyr Ser Cys 
1               5                   10                  15      


Leu His Met Lys Ile Thr Ser Gly Gly Gly 
            20                  25      


<210> 16
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Ile Tyr Ala Ala Tyr Pro Pro Cys Pro Gln Asn Leu Ser Lys Phe Cys 
1               5                   10                  15      


Arg His Ser Ser Ser Pro Gly Gly Gly Gly 
            20                  25      


<210> 17
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Val Glu Asn Pro Trp Asn Gln Cys Met Lys Gly Thr Phe Lys Arg Cys 
1               5                   10                  15      


Ser Tyr Pro Arg Ile Ala Asn Gly Gly Gly 
            20                  25      


<210> 18
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Ala Tyr Pro His Gly Arg Ser Cys Pro Gln Asn Ile Ser Lys Phe Cys 
1               5                   10                  15      


Phe Asp His Glu Lys Thr Asn Gly Gly Gly 
            20                  25      


<210> 19
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Gln Gly Gly Glu Trp His Arg Cys Met Ser Glu Glu Gly Lys His Cys 
1               5                   10                  15      


Val Asp Ile Gln Phe Ile Arg Gly Gly Gly 
            20                  25      


<210> 20
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Thr Ser Leu Thr Val Met Thr Cys Pro His Asn Pro Ser Lys Trp Cys 
1               5                   10                  15      


Ser Pro Leu Pro Ala Ala Val Gly Gly Gly 
            20                  25      


<210> 21
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Ala Met Ala Ser Ser Ala Thr Cys Thr Lys Pro Asn Ser Tyr Ser Cys 
1               5                   10                  15      


Leu His Ala Lys Leu Val Pro Gly Gly Gly 
            20                  25      


<210> 22
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Met Pro Ser Pro Pro Lys Asn Cys Ser Lys Phe His Ser Ala Leu Cys 
1               5                   10                  15      


Lys Gly Val Thr Trp Asn Val Gly Gly Gly 
            20                  25      


<210> 23
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Ser His Pro Gln Glu Phe Trp Cys Pro Gln Asn Phe Ser Lys Phe Cys 
1               5                   10                  15      


Ser Arg Ser Tyr Ser Asn Thr Gly Gly Gly 
            20                  25      


<210> 24
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term Ac

<220>
<221> MISC_FEATURE
<222> (2)..(10)
<223> Disulfide bridge

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Biotin-Lys 

<400> 24
Ala Cys Pro Met Asn Glu Ser Lys Phe Cys Gly Gly Gly Lys 
1               5                   10                  


<210> 25
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term Ac

<220>
<221> MISC_FEATURE
<222> (2)..(10)
<223> Disulfide bridge

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Biotin-Lys

<400> 25
Ala Cys Pro Ser Asn Pro Ser Lys Phe Cys Gly Gly Gly Lys 
1               5                   10                  


<210> 26
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term Ac

<220>
<221> MISC_FEATURE
<222> (2)..(10)
<223> Disulfide bridge

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Biotin-Lys

<400> 26
Ala Cys Pro Lys Asn Pro Asn Lys Phe Cys Gly Gly Gly Lys 
1               5                   10                  


<210> 27
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (8)..(16)
<223> Disulfide bridge

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Biotin-Lys

<400> 27
Ala Tyr Pro His Gly Arg Ser Cys Pro Gln Asn Ile Ser Lys Phe Cys 
1               5                   10                  15      


Phe Asp His Glu Lys Thr Asn Gly Gly Gly Lys 
            20                  25          


<210> 28
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (8)..(16)
<223> Disulfide bridge

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Biotin-Lys

<400> 28
Ser His Pro Gln Glu Phe Trp Cys Pro Gln Asn Phe Ser Lys Phe Cys 
1               5                   10                  15      


Ser Arg Ser Tyr Ser Asn Thr Gly Gly Gly Lys 
            20                  25          


<210> 29
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (2)..(10)
<223> Disulfide bridge

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Biotin-Lys

<400> 29
Ala Cys Pro Arg Asn Glu Ser Lys Phe Cys Gly Gly Gly Lys 
1               5                   10                  


<210> 30
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MISC_FEATURE
<222> (2)..(10)
<223> Disulfide bridge

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Biotin-Lys

<400> 30
Ala Cys Pro Lys Asn Pro Ser Lys Phe Cys Gly Gly Gly Lys 
1               5                   10                  


